The GWAS Explorer is an interactive tool that enables researchers to search, visualize, and download aggregated association results from PLCO Atlas genome-wide association studies (GWAS).
The resource includes association results generated using genotype data from 110,000 PLCO participants, obtained using high-density Illumina arrays and imputed against the TopMed reference panel. The data encompass more than 78 million genomic markers and over 200 cancer and cancer-related phenotypes.
Researchers can visualize association results using interactive Manhattan plots, with options for stratification by sex and ancestry, as well as other diagnostic plots (e.g., Q-q plots) and resources for comparing genetic correlations across phenotypes. Furthermore, descriptive characteristics of the PLCO participants, phenotype annotations, and links to other relevant genomic resources are available.
The Prostate, Lung, Colorectal, Ovarian (PLCO) Cancer Screening Study is a large population-based randomized trial designed and sponsored by the National Cancer Institute (NCI) to determine the effects of screening on cancer-related mortality and secondary endpoints in men and women aged 55 to 74. The screening component of the trial was completed in 2006.